Medical Devices 2011 - Software Verification and Validation Planning and Execution
Date2011-02-22
Deadline2011-02-22
VenuePalo Alto, USA - United States
KeywordsMedical Devices,conference,event,Webinar
Topics/Call fo Papers
Why Should You Attend:
Software and related hardware design, development, verification and validation is difficult to manage, document and control. Where as Software design and development is under increased scrutiny by the new "tougher" U.S. FDA. This is with good reason. Product, production / test equipment, and even the QMS are increasingly software / firmware driven.
This presentation focuses on the verification and validation planning and execution of software after basic developmental testing and de-bug. It includes COTS (commercial off-the-shelf) software. A suggested FDA model will be evaluated, implemented, with V&V documentation and test case examples. The focus is on the most recent issues the FDA has had in this area, and remediation approaches.
Software considered: 1) In-product, 2) As-product, 3) Production and test, and 4) QMS / Pt. 11. Field examples, good and bad will be addressed. We will evaluate the chief areas of FDA concerns to see actual and anticipated changes in emphasis based on this new regulatory climate.
Areas Covered in the Seminar:
Discussion on Recent industry failures.
Tougher FDA Expectations / Requirements.
Roles of Verification and Validation.
An FDA "Model".
A Typical Software V&V Protocol / Test Report.
A Brief Overview of 21 CFR Part 11.
Legacy, Hybrid, New and ER / ES Systems.
Expected Regulatory Deliverables.
Complementary Guidelines, e.g., GAMP.
NOTE: Use This Promocode ( 117660 ) To Get 10% Discount.
Software and related hardware design, development, verification and validation is difficult to manage, document and control. Where as Software design and development is under increased scrutiny by the new "tougher" U.S. FDA. This is with good reason. Product, production / test equipment, and even the QMS are increasingly software / firmware driven.
This presentation focuses on the verification and validation planning and execution of software after basic developmental testing and de-bug. It includes COTS (commercial off-the-shelf) software. A suggested FDA model will be evaluated, implemented, with V&V documentation and test case examples. The focus is on the most recent issues the FDA has had in this area, and remediation approaches.
Software considered: 1) In-product, 2) As-product, 3) Production and test, and 4) QMS / Pt. 11. Field examples, good and bad will be addressed. We will evaluate the chief areas of FDA concerns to see actual and anticipated changes in emphasis based on this new regulatory climate.
Areas Covered in the Seminar:
Discussion on Recent industry failures.
Tougher FDA Expectations / Requirements.
Roles of Verification and Validation.
An FDA "Model".
A Typical Software V&V Protocol / Test Report.
A Brief Overview of 21 CFR Part 11.
Legacy, Hybrid, New and ER / ES Systems.
Expected Regulatory Deliverables.
Complementary Guidelines, e.g., GAMP.
NOTE: Use This Promocode ( 117660 ) To Get 10% Discount.
Other CFPs
- Don't RISK to ignore RISKS. Understanding ISO 14971
- Risk-Based Verification and Validation Planning to Meet U.S. FDA, ICH Q9 and ISO 14971
- Presenting the real GCP handbook - Webinar By ComplianceOnline
- How to Prevent or Handle Protocol Deviations and Violations to be GCP and Regulatory Compliant?
- Responsibilities of a Clinical Research Coordinator managing clinical trial
Last modified: 2011-02-02 18:07:40